Background: Electronic auscultation appears superior to acoustic auscultation for identifying
Introduction
A carotid bruit detected by conventional acoustic auscultation is associated with a 2-4 fold increased risk of transient ischemic attack, stroke and death in general population studies. 1 Diabetes further increases the risk of both a bruit 2 and the subsequent risk of stroke. 3 Metaanalysis suggests that the sensitivity and specificity of a bruit for a ≥70% carotid stenosis detected by ultrasonography, angiography and/or oculoplethysmography are only 53% and 83%, respectively. 4 Nevertheless, current guidelines state that it is reasonable to perform duplex ultrasonography in patients with or without diabetes who have a carotid bruit to determine whether a hemodynamically significant stenosis is present. 5 Ultrasonography remains a noninvasive way of identifying which patients should benefit from optimal medical management including anti-platelet therapy and perhaps further imaging with a view to revascularization. 6, 7 In addition, ultrasonographic measurement of the carotid intima-medial thickness (CIMT) can provide indirect evidence of co-existent coronary artery and/or peripheral vascular disease, [8] [9] [10] further reinforcing the need for optimized cardiovascular risk factor management.
Carotid auscultation using an acoustic stethoscope is a simple tool that requires application of the correct technique in a noise-free environment by a skilled operator who instantaneously interprets what is heard, including differentiation of a bruit from a transmitted cardiac murmur.
When these conditions cannot be met, the opportunity for potentially valuable screening is lost.
The electronic stethoscope has, however, emerged as a way in which a trained non-expert operator can obtain a permanent auscultatory record for later expert interpretation. These digital recordings are of better quality than those obtained using acoustic stethoscopes. 11, 12 This technology has been applied successfully in clinically challenging situations such as in aviation medicine,   12   prisons   13 and remote clinics.
14 The sensitivity and specificity of carotid bruits ascertained by electronic auscultation for ultrasonographically identified carotid stenosis and increased CIMT have not been examined previously. We hypothesized that the use of an electronic stethoscope by a trained non-expert operator with subsequent evaluation by an experienced clinician would improve the diagnosis of carotid atherosclerosis in patients with diabetes.
Subjects and Methods

Patients
We studied participants in the Fremantle Diabetes Study Phase II (FDS2), a community-based prospective observational study conducted in an urban region of approximately 153,000 people.
A detailed description of FDS2 identification/recruitment procedures, sample characteristics, classification of diabetes type and details of non-recruited patients has been published previously. 15 The FDS2 protocol was approved by the Human Research Ethics Committee of the Southern Metropolitan Area Health Service, and all subjects gave informed consent before participation.
Of 1,732 FDS2 subjects recruited between 2008 and 2011, 361 had died or withdrawn by early 2013. Of the 1,371 available for participation in the present sub-study, 84 (6.1%) were identified as having a carotid bruit by electronic auscultation at prior FDS2 assessments. Each of these patients and one age-and gender-matched FDS2 subject without a bruit were invited to undergo carotid Doppler ultrasonography. We did not exclude patients who reported a history/symptoms of cerebrovascular disease or those with prior carotid imaging, but did exclude those who had undergone carotid revascularization subsequent to identification of the bruit.
Clinical assessment
At FDS2 baseline assessment and subsequent biennial reviews, a comprehensive history of diabetes and co-morbidities was recorded, a physical examination was performed by a trained nurse, and fasting blood and urine samples were taken for analyses in a single nationallyaccredited laboratory. Optimized transducer depth (usually 4.0 cm) was adjusted to avoid slice thickness artefacts. The images were captured during systole at the R-waves over 3-4 cardiac cycles. Three edge-to-edge measurements were taken of the far-wall with a CIMT over ≥1 cm lengths without the zoom function. The presence of carotid plaque was defined as focal wall thickening ≥50% greater than that of the surrounding vessel wall or as a focal region with IMT >1.5 mm protruding into the lumen and distinct from the adjacent boundary. 18 Plaques ranged from hard (calcified) to soft (echogenic without calcification).
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Carotid intima-medial thickness threshold and percentile distribution
A fixed CIMT threshold of ≥1.0 mm is considered an adverse cardiovascular indicator. 19, 20 In and similar diabetes duration (see Table 1 ). The cases had a lower diastolic but similar systolic blood pressure to the controls, consistent with a wider pulse pressure, and their serum HDLcholesterol concentrations were higher.
The carotid ultrasound parameters and SHAPE categories are summarized in The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of a carotid bruit for each parameter are detailed in Table 3 . The sensitivity of an electronically detected carotid bruit for a stenosis of ≥70% was 83% with a modest specificity of 52%. For a stenosis of ≥50%, the specificity and sensitivity were both higher but the NPV was >96% in both cases. For CIMT >1.0 mm, CIMT ≥75th percentile, and the presence of plaque, sensitivity and specificity ranged between 60% and 75%. After exclusion of eight case/control pairs that included at least one patient who had reported a history of carotid artery disease or prior ultrasonographic assessment prompted by symptoms, the sensitivity of a bruit for a stenosis of ≥50% or ≥70% increased to 100% but with wider 95% confidence intervals (see Table 3 ).
Discussion
The present data show that carotid bruits identified by an electronic stethoscope in communitybased patients with diabetes have high sensitivity (>83%) and NPV (>96%) for both moderate (≥50%) and high grade (≥70%) carotid stenoses detected subsequently by carotid duplex ultrasonography. Given that the PPV was low (≤30%), these observations suggest that most of the patients with carotid stenoses had an overlying bruit but that most bruits were false positives, and that the absence of a bruit was rarely a false negative finding. The practical implications of these observations are that i) electronic recording of carotid sounds by a trained operator for later transmission and interpretation appears reliable when expert acoustic auscultation is unavailable, ii) patients with diabetes who have no carotid bruit detected in this way can usually be reassured that they do not have hemodynamically important carotid atherosclerosis, iii) patients with diabetes and a carotid bruit will usually not have a significant (≥70%) stenosis but, consistent with current guidelines, 5 duplex ultrasonography should still be recommended to more objectively document the extent of disease, and iv) measurement of the CIMT patients with diabetes and a carotid bruit will identify increased vascular risk in most of these patients regardless of the presence of stenosis.
A recent meta-analysis of studies examining the utility of carotid bruits ascertained using an acoustic stethoscope for clinically significant carotid stenoses (>70%) generated a pooled sensitivity of 53% and a specificity of 83%. 4 The higher sensitivity and lower specificity found in the present study could be due to several factors. First, the better acoustic quality obtained using the electronic stethoscope 11, 12 may have meant that more bruits were detected. This includes softer bruits both associated with reduced flow in severely stenosed vessels 24 thus increasing sensitivity, and as a manifestation of low grade stenoses or vascular tortuosity which would attenuate specificity and PPV. Indeed, the prevalence of bruits detected by acoustic stethoscope in the first phase of the FDS (FDS1) between 1993 and 1996 was lower at 4.5% 11 potentially reduce sensitivity. Infra-clavicular auscultation was not performed in a number of studies 7, 25, 26 and, in another, ascertainment of bruits was based solely on the referring physician's assessment. 27 The cost-effectiveness of screening for asymptomatic carotid artery stenosis using duplex ultrasonography has not been assessed through a randomized clinical trial. It remains contentious and dependent on key variables such as the stenotic threshold for intervention (which has been set at 50%, 60% and 70%), the prevalence of stenosis in the target population (which can be increased, for example, by including only older men), and treatment outcomes (especially when assessment and intervention are not carried out in centers of excellence).
28-30
Indeed the sensitivity and specificity of duplex ultrasonography itself compared with angiography are variable in published studies, [31] [32] [33] but typically ≥90% for a stenosis ≥70%. 29 Although a formal health economic evaluation would be required, our data suggest that pre-screening with electronic auscultation could improve cost-effectiveness, especially since specificity and NPV were both >96% in our asymptomatic patients.
There is evidence that carotid bruits are more predictive of cardiovascular than cerebrovascular disease outcomes including death. 10, 34 CIMT is a proven indicator of cardiovascular risk and can refine assessment of patients at intermediate risk. 18 Our data demonstrate that the presence of a carotid bruit increases the likelihood of a CIMT ≥1 mm three-fold. There were also 50% more patients with carotid plaques in the group with detectable carotid bruits. A recently published editorial suggested that a combination of CIMT ≥1 mm and carotid plaque might improve coronary risk prediction more than either parameter alone,
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incorporate these variables independently. 22 Indeed, almost one third of our patients with bruits were in the very high SHAPE vascular risk category compared with only 4% of those without bruits. Thus, observations and measures other than degree of carotid stenosis can inform management since patients assessed at very high risk are recommended to have a stricter serum LDL cholesterol target (<1.8 mmol/L) than other categories and to be considered for investigation of myocardial ischemia such as through an exercise stress test. 22 Indeed, most of our patients, including those with a CIMT ≥1 mm and/or a carotid bruit, had a serum LDL cholesterol ≥1.8 mmol/L despite the fact that the majority were taking lipid-modifying agents (largely statins), suggesting that therapeutic intensification may be possible. The apparently paradoxical higher serum HDL cholesterol concentrations in those with carotid bruits is most likely a chance finding.
There was a trend to increased carotid artery tortuosity in the patients with carotid bruits, especially for at least moderate degrees of this vascular anomaly which was independent of the presence of high grade (≥70%) stenosis. Mild tortuosity is a relatively common asymptomatic finding, 36 but there is debate as to the significance of more severe tortuosity. It has been associated with atherosclerosis and its risk factors including hypertension, 36 and it predicts subsequent intra-procedural complications in patients undergoing carotid artery stenting, 37 but its prognostic value for cerebrovascular events is uncertain. 38 In the present study, at least moderately severe tortuosity was present in one in five patients with carotid bruit and may have explained why a bruit was readily detected by electronic auscultation in these subjects.
Our study had limitations. We recruited only 100 patients but our sample size was restricted by the prevalence of bruits in the large FDS2 cohort. Nevertheless, FDS2 patients appear representative of people with diabetes in a large urban Australian community, 15 while the similarities in demographic variables between those with carotid bruits who participated in the present sub-study and the 33 who did not suggests that there was no significant recruitment bias.
We did not perform simultaneous acoustic auscultation as our aim was to assess use of the electronic stethoscope against reference ultrasonography. It is likely, however, that electronic capture of carotid sounds is more reliable based on the greater prevalence of bruits in FDS2 vs FDS1 6.1% vs 4.5% 3 and other studies directly comparing the two methods.
11, 12
The present study suggests that electronic auscultation is more accurate than a conventional acoustic stethoscope for the detection of carotid bruits in patients with diabetes, while offering the convenience of later interpretation if a skilled operator is not available when the patient is assessed. The presence of a bruit identified in this way should prompt i) intensified cardiovascular risk factor management and ii) consideration of ultrasonography and perhaps other imaging with a view to revascularization depending on symptoms and factors such as age and co-morbidities. The absence of a bruit does not exclude a hemodynamically significant stenosis but there may be other indications of cerebrovascular disease. For example, in our patient without a bruit who had an occluded carotid artery, there was a history of cerebrovascular symptoms and evidence of established vascular disease at other sites which is itself collateral evidence of significant carotid stenosis risk. 10, 34 The cost of the electronic stethoscope and software used in the present study is approximately twice that of a high quality acoustic model, suggesting that it is affordable technology even in basic healthcare settings. case/control pairs, both of whom had no prior symptoms of carotid arterial disease, are also
shown.
